Sakys John's Form 4 filing
Mesa Laboratories Inc (MLAB) · filed Feb 9, 2023
- Accession no.
- 0001228924-23-000005
- Filed
- Feb 9, 2023
- Trade date
- Feb 9, 2023
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $184.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sakys JohnCIK 0001197710 | Officer (CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | Common Stock | MOption exerciseAcquired | +1,000 | $51.85 | +$51,850 | 10,696 | Direct | |
| Feb 9, 2023 | Common Stock | SSaleDisposed | −1,000 | $184.27 | −$184,270 | 9,696 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 9, 2023 | Common Stock | XIn-the-money exerciseDisposed | −1,000 | $0.00 | $0 | 26,702 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.